Welcome to our dedicated page for XOMA Royalty Corporation SEC filings (Ticker: XOMAP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
XOMA Royalty Corporation's filings document the capital structure and public-company reporting for its common stock, 8.625% Series A Cumulative Perpetual Preferred Stock (XOMAP), and depositary shares representing interests in its Series B preferred stock on Nasdaq. Recent 8-K disclosures address financial results, Regulation FD materials, material definitive agreements and the completed acquisition of Generation Bio, including supplemental information about legacy assets.
Proxy materials describe annual meeting proposals, shareholder voting procedures and governance matters. For the preferred security, the filing record identifies the registered preferred-stock class and places capital-structure and transaction disclosures in the context of XOMA Royalty's biotechnology royalty aggregation business.